UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications

The journal of clinical psychiatry, 2011-04, Vol.72 (4), p.464-472

2011

Volltextzugriff (PDF)

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration

The journal of clinical psychiatry, 2012-06, Vol.73 (6), p.856-864

2012

Volltextzugriff (PDF)

What's next after 50 years of psychiatric drug development: an FDA perspective

The journal of clinical psychiatry, 2010-09, Vol.71 (9), p.1196-1204

Laughren, Thomas P

2010

Volltextzugriff (PDF)

CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendations

The journal of clinical psychiatry, 2012-09, Vol.73 (9), p.1187-1190

2012

Volltextzugriff (PDF)

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant

The journal of clinical psychiatry, 2011-09, Vol.72 (9), p.1166-1173

2011

Volltextzugriff (PDF)

Suicide rates in short-term randomized controlled trials of newer antidepressants

Journal of clinical psychopharmacology, 2006-04, Vol.26 (2), p.203-207

2006

Volltextzugriff (PDF)

Female reproductive life cycle and hormones: methodology to improve clinical trials

The journal of clinical psychiatry, 2013-10, Vol.74 (10), p.1018

2013

Volltextzugriff (PDF)

An integrated approach for establishing dosing recommendations: paliperidone for the treatment of adolescent schizophrenia

Journal of clinical psychopharmacology, 2013-04, Vol.33 (2), p.152-156

2013

Volltextzugriff (PDF)

FDA Perspective on the DSM-5 Approach to Classification of “Cognitive” Disorders

The journal of neuropsychiatry and clinical neurosciences, 2011-04, Vol.23 (2), p.126-131

Laughren, Thomas

2011

Volltextzugriff (PDF)

Developing novel treatments for mood disorders: accelerating discovery

Biological Psychiatry, 2002-09, Vol.52 (6), p.589-609

2002

Volltextzugriff (PDF)

The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?

Schizophrenia bulletin, 2011-11, Vol.37 (6), p.1209-1217

2011

Volltextzugriff (PDF)

Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop

Schizophrenia bulletin, 2007-05, Vol.33 (3), p.805-822

2007

Volltextzugriff (PDF)

Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders

Journal of affective disorders, 2014-10, Vol.168, p.439-451

2014

Volltextzugriff (PDF)

Food and drug administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim : Negative symptoms

Schizophrenia bulletin, 2006, Vol.32 (2), p.220-222

2006

Volltextzugriff (PDF)

Suicidality in pediatric patients treated with antidepressant drugs

Archives of general psychiatry, 2006-03, Vol.63 (3), p.332

2006

Volltextzugriff (PDF)

Developing Strategies for Psychopharmacological Studies in Preschool Children

Journal of the American Academy of Child and Adolescent Psychiatry, 2003-04, Vol.42 (4), p.406-414

2003

Volltextzugriff (PDF)

Mood disorders in the Medically. III: Scientific review and recommendations

Biological psychiatry (1969), 2005, Vol.58 (3), p.175-189

2005

Volltextzugriff (PDF)

Neuroleptic bioavailability, psychosocial factors, and clinical status: A 1-year study of schizophrenic outpatients after dose reduction

Psychiatry research, 1986-12, Vol.19 (4), p.311-322

1986

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

ThemaPsychology. Psychoanalysis. Psychiatry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration

What's next after 50 years of psychiatric drug development: an FDA perspective

CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendations

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant

Suicide rates in short-term randomized controlled trials of newer antidepressants

Female reproductive life cycle and hormones: methodology to improve clinical trials

An integrated approach for establishing dosing recommendations: paliperidone for the treatment of adolescent schizophrenia

FDA Perspective on the DSM-5 Approach to Classification of “Cognitive” Disorders

Developing novel treatments for mood disorders: accelerating discovery

The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?

Assessment of Community Functioning in People With Schizophrenia and Other Severe Mental Illnesses: A White Paper Based on an NIMH-Sponsored Workshop

Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders

Food and drug administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim : Negative symptoms

Suicidality in pediatric patients treated with antidepressant drugs

Developing Strategies for Psychopharmacological Studies in Preschool Children

Mood disorders in the Medically. III: Scientific review and recommendations

Neuroleptic bioavailability, psychosocial factors, and clinical status: A 1-year study of schizophrenic outpatients after dose reduction

Aktive Filter

Suchergebnisse filtern